Koninklijke Philips N.V. $PHG Shares Bought by Russell Investments Group Ltd.

Russell Investments Group Ltd. grew its stake in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 7.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 482,753 shares of the technology company's stock after acquiring an additional 31,535 shares during the period. Russell Investments Group Ltd. owned about 0.05% of Koninklijke Philips worth $12,262,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its holdings in Koninklijke Philips by 2.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,290,051 shares of the technology company's stock worth $108,624,000 after acquiring an additional 85,994 shares in the last quarter. Northern Trust Corp grew its holdings in Koninklijke Philips by 36.6% during the 4th quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company's stock worth $40,734,000 after acquiring an additional 430,757 shares in the last quarter. Becker Capital Management Inc. grew its holdings in Koninklijke Philips by 0.7% during the 4th quarter. Becker Capital Management Inc. now owns 945,542 shares of the technology company's stock worth $23,941,000 after acquiring an additional 6,475 shares in the last quarter. GAMMA Investing LLC grew its holdings in Koninklijke Philips by 3,094.8% during the 1st quarter. GAMMA Investing LLC now owns 350,241 shares of the technology company's stock worth $8,896,000 after acquiring an additional 339,278 shares in the last quarter. Finally, Pathstone Holdings LLC grew its holdings in Koninklijke Philips by 6.3% during the 4th quarter. Pathstone Holdings LLC now owns 328,252 shares of the technology company's stock worth $8,311,000 after acquiring an additional 19,545 shares in the last quarter. 13.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Buy".

Koninklijke Philips Stock Performance

NYSE:PHG traded up $0.7250 during mid-day trading on Friday, hitting $28.1650. The stock had a trading volume of 284,307 shares, compared to its average volume of 990,661. The stock has a market capitalization of $27.12 billion, a price-to-earnings ratio of 148.29, a P/E/G ratio of 0.75 and a beta of 0.75. The company has a 50 day simple moving average of $25.11 and a 200-day simple moving average of $25.02. Koninklijke Philips N.V. has a 52 week low of $21.48 and a 52 week high of $32.91. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69.

Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.12. The firm had revenue of $5.05 billion for the quarter, compared to the consensus estimate of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. On average, research analysts expect that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.